Kiwoom PE Fund

Kiwoom PE Fund is a buyout fund managed by Kiwoom Asset Management, based in Seoul, South Korea. The fund specializes in acquiring and managing companies, focusing on generating long-term value through strategic investments. Kiwoom Investment, the parent firm, was founded in 1999 and has established itself as a prominent venture capital entity in the region. The firm invests across various sectors, including information and communication technology, bio and medical industries, consumer goods, and financial services. Kiwoom PE Fund benefits from the firm’s extensive experience and diverse investment portfolio, allowing it to identify opportunities that align with market trends and emerging technologies.

27 past transactions

Enerever

Series B in 2022
Enerever Battery Solution is a leading manufacturer in South Korea specializing in battery coating products and separators. The company produces eco-friendly materials for secondary batteries, focusing on water-based coatings that provide uniform thickness while preserving the integrity of individual particles. This innovative approach enables manufacturers in various sectors, including electric vehicles, mobile phones, and e-bicycles, to utilize efficient coating solutions for their battery production. Additionally, Enerever is the only comprehensive separator company in Korea, offering services that include fabric coating, slitting, and battery can manufacturing. Through its advanced technologies, Enerever plays a significant role in enhancing the performance and sustainability of battery materials.

Spark Biopharma

Series C in 2022
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Metsakuur

Series A in 2022
Mesacour Company has its own original face recognition technology and is made up of people who have worked with face recognition technology in a variety of industries. Messacour's face recognition accuracy is 100%, which is the highest level in the world.

Fintech

Series A in 2021
Fintech is a leading data solution service company.

N.thing

Series B in 2021
N.THING, Inc. is an innovative company based in South Korea, specializing in the integration of Internet of Things (IoT) technologies within the gardening and agriculture sectors. Founded in January 2014, N.THING aims to foster a connection between people and nature through its various products and applications. The company offers a range of smart gardening solutions, including the Planty Cube, an internet-connected indoor farm equipped with LED technology and real-time monitoring systems; the Planty Square, a modular hydroponic kit that allows users to grow greens and herbs; and the Planty, the world's first internet-connected social pot, which enables users to monitor and care for their plants remotely. Additionally, the Life app serves as a digital gardening journal, allowing users to track their gardening activities and share experiences via social media. N.THING's mission is to simplify the gardening experience, making it accessible and enjoyable for everyone.

N.thing

Series B in 2021
N.THING, Inc. is an innovative company based in South Korea, specializing in the integration of Internet of Things (IoT) technologies within the gardening and agriculture sectors. Founded in January 2014, N.THING aims to foster a connection between people and nature through its various products and applications. The company offers a range of smart gardening solutions, including the Planty Cube, an internet-connected indoor farm equipped with LED technology and real-time monitoring systems; the Planty Square, a modular hydroponic kit that allows users to grow greens and herbs; and the Planty, the world's first internet-connected social pot, which enables users to monitor and care for their plants remotely. Additionally, the Life app serves as a digital gardening journal, allowing users to track their gardening activities and share experiences via social media. N.THING's mission is to simplify the gardening experience, making it accessible and enjoyable for everyone.

Travel Wallet

Series B in 2021
Developer of a mobile-based foreign currency platform designed to provide digital travel wallet services. The company's platform includes a currency exchange service, real-time exchange rates, an exchange rate calculator, local cash pick-up, physical card issuance, and an exchange rate graph, enabling tourists and business travelers to get fast and easy money exchange service at a competitive rate compared to retail banks.

TRU Technologies

Series A in 2021
TRU Technologies is a technology company focusing on developing and operating Securities Finance software products.
OliX Pharmaceuticals is a clinical stage biotechnology company based in Suwon, South Korea, specializing in the development of RNA interference (RNAi) therapeutics aimed at treating various dermal, ophthalmic, and pulmonary diseases. The company's diverse product pipeline includes treatments such as OLX101 for skin scars, OLX102 for skin whitening, OLX103 for atopic dermatitis, OLX104 for hair loss, OLX105 for anti-wrinkle applications, and OLX106 for diabetic foot ulcers. Additionally, it is developing therapies for age-related macular degeneration, retinitis pigmentosa, lung fibrosis, asthma, influenza, neuropathic pain, liver fibrosis, and cancer immunotherapy. OliX Pharmaceuticals has also formed a collaboration with Théa to advance SiRNA therapeutics specifically for ophthalmic conditions. Established in 2010, the company leverages its proprietary RNAi technology to regulate the expression of genes associated with diseases.

ILIAS Biologics

Series B in 2020
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.

Parameta

Series B in 2020
ICONLOOP, Inc. is a blockchain-specialized tech company based in Seoul, South Korea. Founded in May 2016, ICONLOOP provides the entire technical support to the leading global blockchain project, ICON. ICONLOOP aims to acquire both scalability and security in existing platforms and maximize the utility of blockchain technology with SCORE Smart Contract, LFT Algorithm, Tiered System, Multi Channel and Modular Architecture. Based on self-developed blockchain engine, loopchain, ICONLOOP, as a technology partner of Korea Financial Investment Association, Kyobo Life Insurance, and P-HIS consortium, leads diverse innovations in financial transactions, digital currency and IoT(Internet of Things).

Onpoint Ecommerce

Series A in 2020
Onpoint E-commerce, founded in 2016 and based in Ho Chi Minh City, Vietnam, specializes in providing customized, all-in-one eCommerce solutions tailored for brands. The company focuses on enhancing the online retail experience through services such as commercial management, merchandising enhancement, online marketing, and B2C order operations. By partnering with brands, Onpoint aims to drive success in the Vietnamese and Southeast Asian markets, fostering value for businesses, consumers, and partners alike.

Odd Concepts

Series B in 2020
Odd Concepts Inc. develops computer vision and artificial intelligence technology solutions. The company’s products include an image recognition platform which is a portfolio of ready to use image recognition and search technology, as a cloud based API service and computer vision consulting. It develops an online software technology for video content searches to link offline shopping businesses to create O2O market. The company was incorporated in 2012 and is based in Seoul, South Korea.

Bluepoint Partners

Venture Round in 2020
Bluepoint Partners is a partnership-driven startup accelerator and early stage VC fund that concentrates on bridging talented high tech entrepreneurs to launching progressive startups with real global solutions. Our partners and accelerating experts work hand-in-hand with entrepreneurs enabling them to build, make key connections, launch, grow, and raise capital to continue their company’s vision and journey. Our family of offices in Deajeon (Tech Valley) and Seoul (Gangnam) keeps us very close and committed to the multi faceted high tech communities. We host workshops and private events designed to bring our entrepreneurs closer to our family of networks that includes strategic relationships to VCs, partnerships, talent, advisors, press, and key introductions for M&A. We form deep relationships with our entrepreneurs so we can venerate their unique qualities and play to their strengths. Together we make a Bluepoint Family.

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

One Store

Venture Round in 2019
One Store is a mobile app market that allows users to download apps that are limited in Korea only. It is run by mobile carriers SK Telecom, KT, LG Uplus and tech company Naver. It has combined its own four different platforms for Android-based smartphones and other mobile devices. Users can upgrade one of the apps to use One Store. It can be used on Android phones and tablets in Korea. It provides games, apps, mobile commerce, e-books, and video content to 35 million members. It was founded in 2016 and is headquartered in Seongnam Gyeonggi-do, South Korea.

Market Designers

Series B in 2019
Developer of an on-demand matching platform designed to connect service providers with customers. The company's platform uses algorithms and on-demand experience to match customers' needs with service areas such as professional moving, cleaning, mortgage, and education, enabling service providers to increase their visibility and expand their client base.

rainist / 레이니스트

Series C in 2019
Rainist Co., Ltd. is a South Korean financial technology company founded in 2012 and based in Seoul. The company develops a financial application known as BankSalad, which collects and analyzes users' financial data to provide recommendations for expenditure analysis and personal financial management. BankSalad also offers tailored suggestions for financial products, such as credit cards, based on users' spending patterns. Through these services, Rainist aims to enhance individuals' financial decision-making and improve their overall financial well-being.

Cogent Labs

Series B in 2019
Cogent Labs Inc., founded in 2015 and based in Tokyo, Japan, specializes in the development of artificial intelligence software aimed at enhancing data input and API documentation. The company focuses on both fundamental and applied AI research, striving to create practical solutions that improve quality of life. Their expertise spans various fields, including time-series forecasting, information extraction, natural language processing, voice processing, and reinforcement learning. Through its innovative approach, Cogent Labs bridges the gap between advanced AI technologies and real-world applications.

rainist / 레이니스트

Series A in 2017
Rainist Co., Ltd. is a South Korean financial technology company founded in 2012 and based in Seoul. The company develops a financial application known as BankSalad, which collects and analyzes users' financial data to provide recommendations for expenditure analysis and personal financial management. BankSalad also offers tailored suggestions for financial products, such as credit cards, based on users' spending patterns. Through these services, Rainist aims to enhance individuals' financial decision-making and improve their overall financial well-being.

Huuuge

Series B in 2016
Huuuge, Inc. is a game developer and publisher specializing in mobile social casino games. Founded in 2015 and based in Palo Alto, California, the company aims to create a large-scale real-time social casual gaming platform that connects millions of players worldwide. Huuuge focuses on enhancing the mobile gaming experience by transforming casual gaming into engaging, social interactions. The company primarily generates revenue through in-app purchases and advertisements within its games, which encompass various categories including arcade, puzzle, and casino genres. Huuuge is dedicated to becoming a leader in the free-to-play mobile gaming sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.